muscle-health
(3)
Scott Magargee
Scott Magargee is the CEO and co-founder of Springbok Analytics, a Charlottesville, Virginia company that turns ordinary MRI scans into FDA-cleared, AI-built 3D maps of every muscle in the human body. A former Princeton history major and Top 100 law firm litigator, he traded courtrooms for muscle health, joining the University of Virginia spinout in December 2019 and steering it through a $5M oversubscribed Series A in January 2025 backed by the NBA. Under his watch, Springbok has scanned elite athletes, pro basketball leagues, and clinical-trial patients, chasing a single idea: make muscle visible, measurable, and actionable.
Alexander Casdin
Alexander Casdin is the Chief Executive Officer of Epirium Bio, a San Diego biotechnology company developing small-molecule therapies to improve muscle function. A healthcare executive and institutional investor with more than 25 years in the industry, he stepped up from CFO and COO to CEO on January 1, 2025, the same month Epirium's lead drug MF-300 - a first-in-class oral 15-PGDH inhibitor for sarcopenia - cleared the FDA to begin human trials. Before Epirium he founded and ran Reneo Capital Management, was CFO of Sophiris Bio, and ran VP of Finance at Amylin Pharmaceuticals, and he sits on the board of Erasca as audit committee chair.
Springbok Analytics
Springbok Analytics is a Charlottesville, Virginia AI company spun out of the University of Virginia that turns standard 2D MRI scans into precise, interactive 3D maps of the musculoskeletal system. Its FDA-cleared platform quantifies up to ~140 individual muscles - measuring volume, fat infiltration, asymmetry, scar tissue, edema and tendon morphology - to create a 'digital muscle twin' used by elite sports teams, clinical researchers, and longevity programs to assess injury risk, track rehab, and monitor age-related muscle change.